Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques

Tools
- Tools
+ Tools

Hattersley, John G., Möhlig, Matthias, Roden, Michael, Dr., Arafat, Ayman M., Loeffelholz, Christian von, Nowotny, Peter, Machann, Jürgen, Hierholzer, Johannes, Osterhoff, Martin, Khan, Michael, Pfeiffer, Andreas F. H. and Weickert, Martin O.. (2012) Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques. PLoS ONE, Vol.7 (No.6). Article no. e39029. ISSN 1932-6203

[img]
Preview
Text
WRAP_Weickert_journal.pone.0039029.pdf - Published Version

Download (297Kb) | Preview
Official URL: http://dx.doi.org/10.1371/journal.pone.0039029

Abstract

We evaluated the ability of simple and complex surrogate-indices to identify individuals from an overweight/obese cohort with hepatic insulin-resistance (HEP-IR). Five indices, one previously defined and four newly generated through step-wise linear regression, were created against a single-cohort sample of 77 extensively characterised participants with the metabolic syndrome (age 55.6±1.0 years, BMI 31.5±0.4 kg/m2; 30 males). HEP-IR was defined by measuring endogenous-glucose-production (EGP) with [6–62H2] glucose during fasting and euglycemic-hyperinsulinemic clamps and expressed as EGP*fasting plasma insulin. Complex measures were incorporated into the model, including various non-standard biomarkers and the measurement of body-fat distribution and liver-fat, to further improve the predictive capability of the index. Validation was performed against a data set of the same subjects after an isoenergetic dietary intervention (4 arms, diets varying in protein and fiber content versus control). All five indices produced comparable prediction of HEP-IR, explaining 39–56% of the variance, depending on regression variable combination. The validation of the regression equations showed little variation between the different proposed indices (r2 = 27–32%) on a matched dataset. New complex indices encompassing advanced measurement techniques offered an improved correlation (r = 0.75, P<0.001). However, when validated against the alternative dataset all indices performed comparably with the standard homeostasis model assessment for insulin resistance (HOMA-IR) (r = 0.54, P<0.001). Thus, simple estimates of HEP-IR performed comparable to more complex indices and could be an efficient and cost effective approach in large epidemiological investigations.

Item Type: Journal Article
Subjects: Q Science > QA Mathematics
R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI)
Library of Congress Subject Headings (LCSH): Insulin resistance -- Diagnosis, Epidemiology -- Statistical methods
Journal or Publication Title: PLoS ONE
Publisher: PLOS
ISSN: 1932-6203
Date: 2012
Volume: Vol.7
Number: No.6
Page Range: Article no. e39029
Identification Number: 10.1371/journal.pone.0039029
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access
Funder: Germany. Bundesministerium für Bildung und Forschung (BMBF)
Grant number: 0313826A (BMBF)
References: 1. Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773–795. 2. Vangipurapu J, Stancakova A, Kuulasmaa T, Paananen J, Kuusisto J, et al. (2011) A novel surrogate index for hepatic insulin resistance. Diabetologia 54: 540–543. 3. Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48: 2197–2203. 4. Mari A (2006) Methods of Assessment of Insulin Sensitivity and b-Cell Function. Immun, Endoc & Metab Agents - Med Chem 6: 1–14. 5. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, et al. (2002) Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 283: E1135–1143. 6. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, et al. (2004) The EGIRRISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47: 566–570. 7. Weickert MO, Roden M, Isken F, Hoffmann D, Nowotny P, et al. (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94: 459–471. 8. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. Lancet 366: 1059–1062. 9. Forster MR (2000) Key Concepts in Model Selection: Performance and Generalizability. J Math Psychol 44: 205–231. 10. Weickert MO, Arafat AM, Blaut M, Alpert C, Becker N, et al. (2011) Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond) 8: 90. 11. Weickert MO, Loeffelholz CV, Roden M, Chandramouli V, Brehm A, et al. (2007) A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab 293: E1078–1084. 12. Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, et al. (2007) Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 4: e154. 13. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, et al. (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21: 455–462. 14. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, et al. (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50: 1072–1078. 15. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, et al. (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44: 27–33. 16. Yilmaz Y (2009) Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther 30: 1103–1109. 17. Campioni M, Toffolo G, Basu R, Rizza RA, Cobelli C (2009) Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters. Am J Physiol Endocrinol Metab 297: E941–948. 18. Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, et al. (2008) Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 47: 484–492. 19. Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 49: 306–317. 20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412– 419. 21. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89–94. 22. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, et al. (2003) Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 26: 3315–3319. 23. Klo¨ting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, et al. (2010) Insulinsensitive obesity. Am J Physiol Endocrinol Metab 299: E506–515. 24. Gibbons G (2005) Old fat, make way for new fat. Nat Med 11: 722–723. 25. Weickert MO, Pfeiffer AF (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49: 1732–1741. 26. Rigalleau V, Blanchetier V, Combe C, Guillot C, Deleris G, et al. (1997) A lowprotein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr 65: 1512–1516. 27. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, et al. (1995) Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38: 565–572.
URI: http://wrap.warwick.ac.uk/id/eprint/48050

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us